Zimmermann Karin, Cignacco Eva, Engberg Sandra, Ramelet Anne-Sylvie, von der Weid Nicolas, Eskola Katri, Bergstraesser Eva, Ansari Marc, Aebi Christoph, Baer Reta, Popovic Maja Beck, Bernet Vera, Brazzola Pierluigi, Bucher Hans Ulrich, Buder Regula, Cagnazzo Sandra, Dinten Barbara, Dorsaz Anouk, Elmer Franz, Enriquez Raquel, Fahrni-Nater Patricia, Finkbeiner Gabi, Frey Bernhard, Frey Urs, Greiner Jeannette, Hassink Ralph-Ingo, Keller Simone, Kretschmar Oliver, Kroell Judith, Laubscher Bernard, Leibundgut Kurt, Malaer Reta, Meyer Andreas, Stuessi Christoph, Nelle Mathias, Neuhaus Thomas, Niggli Felix, Perrenoud Geneviève, Pfammatter Jean-Pierre, Plecko Barbara, Rupf Debora, Sennhauser Felix, Stade Caroline, Steinlin Maja, Stoffel Lilian, Thomas Karin, Vonarburg Christian, von Vigier Rodo, Wagner Bendicht, Wieland Judith, Wernz Birgit
Department Public Health (DPH), Nursing Science, University of Basel, Bernoullistrasse 28, 4056, Basel, Switzerland.
Paediatric Palliative Care, University Children's Hospital Zurich, Children's Research Center CRC, Steinwiesstrasse 75, 8032, Zurich, Switzerland.
BMC Pediatr. 2018 Feb 16;18(1):67. doi: 10.1186/s12887-018-1021-2.
Paediatric end-of-life care is challenging and requires a high level of professional expertise. It is important that healthcare teams have a thorough understanding of paediatric subspecialties and related knowledge of disease-specific aspects of paediatric end-of-life care. The aim of this study was to comprehensively describe, explore and compare current practices in paediatric end-of-life care in four distinct diagnostic groups across healthcare settings including all relevant levels of healthcare providers in Switzerland.
In this nationwide retrospective chart review study, data from paediatric patients who died in the years 2011 or 2012 due to a cardiac, neurological or oncological condition, or during the neonatal period were collected in 13 hospitals, two long-term institutions and 10 community-based healthcare service providers throughout Switzerland.
Ninety-three (62%) of the 149 reviewed patients died in intensive care units, 78 (84%) of them following withdrawal of life-sustaining treatment. Reliance on invasive medical interventions was prevalent, and the use of medication was high, with a median count of 12 different drugs during the last week of life. Patients experienced an average number of 6.42 symptoms. The prevalence of various types of symptoms differed significantly among the four diagnostic groups. Overall, our study patients stayed in the hospital for a median of six days during their last four weeks of life. Seventy-two patients (48%) stayed at home for at least one day and only half of those received community-based healthcare.
The study provides a wide-ranging overview of current end-of-life care practices in a real-life setting of different healthcare providers. The inclusion of patients with all major diagnoses leading to disease- and prematurity-related childhood deaths, as well as comparisons across the diagnostic groups, provides additional insight and understanding for healthcare professionals. The provision of specialised palliative and end-of-life care services in Switzerland, including the capacity of community healthcare services, need to be expanded to meet the specific needs of seriously ill children and their families.
儿科临终关怀具有挑战性,需要高水平的专业知识。医疗团队全面了解儿科亚专业以及儿科临终关怀疾病特定方面的相关知识非常重要。本研究的目的是全面描述、探索和比较瑞士不同医疗机构中四个不同诊断组的儿科临终关怀当前实践,涵盖所有相关医疗服务提供者级别。
在这项全国性回顾性病历审查研究中,收集了2011年或2012年在瑞士13家医院、两家长期机构和10家社区医疗服务提供者处因心脏、神经或肿瘤疾病死亡的儿科患者,以及新生儿期死亡患者的数据。
149例接受审查的患者中有93例(62%)在重症监护病房死亡,其中78例(84%)在撤除维持生命治疗后死亡。对侵入性医疗干预的依赖普遍存在,药物使用量很大,在生命的最后一周使用的不同药物中位数为12种。患者平均经历6.42种症状。四个诊断组中各种症状的患病率差异显著。总体而言,我们研究中的患者在生命的最后四周在医院的中位停留时间为六天。72例患者(48%)至少在家中度过一天,其中只有一半接受了社区医疗服务。
该研究广泛概述了不同医疗服务提供者在现实环境中的当前临终关怀实践。纳入所有导致与疾病和早产相关的儿童死亡的主要诊断患者,以及跨诊断组的比较,为医疗专业人员提供了更多的见解和理解。瑞士需要扩大提供专门的姑息和临终关怀服务,包括社区医疗服务能力,以满足重症儿童及其家庭的特殊需求。